Inventiva S.A.
IVANext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for IVA. That does not mean none is planned.
Get an email about IVA's next catalysts
Track Inventiva (IVA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
IVA337
NASH - Nonalcoholic Steatohepatitis
Odiparcil
Mucopolysaccharidosis VI
Lanifibranor
NASH - Nonalcoholic Steatohepatitis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
IVA337 | Phase 3 | NASH - Nonalcoholic Steatohepatitis | - | - |
Odiparcil | Phase 2 | Mucopolysaccharidosis VI | - | - |
Lanifibranor | Phase 2 | NASH - Nonalcoholic Steatohepatitis | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Inventiva S.A.'s drug pipeline?→
CatalystAlert tracks 3 drug candidates in Inventiva S.A.'s (IVA) pipeline across Phase 3, Phase 2. Its lead program is IVA337 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Inventiva S.A.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Inventiva S.A. (IVA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track IVA biotech catalysts?→
Add IVA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Inventiva S.A.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.